Paper346153
Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms?
Maurice-Williams RS. Br Med J, 1978. Cited by 82 papers, by iCite.
Cite this record
ConductScience Library. Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms? Papers, record 346153. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/346153
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms?
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclohexanecarboxylic Acids | Major topic |
| Intracranial Aneurysm | Major topic |
| Tranexamic Acid | Major topic |
| Clinical Trials as Topic | |
| Humans | |
| Recurrence | |
| Rupture, Spontaneous | |
| Subarachnoid Hemorrhage |
Source PubMed
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14107926 | MULTIPLE INTRACRANIAL ANEURYSMS. | Lancet | 1964 | https://conductscience.org/library/papers/14107926 | PubMed |
| 2 | 963461 | Intracranial aneurysms: analysis of results of microneurosurgery. | Br Med J | 1976 | https://conductscience.org/library/papers/963461 | PubMed |
| 3 | 4127547 | Specific and sensitive determination of fibrinogen-degradation products by radioimmunoassay. | Lancet | 1973 | https://conductscience.org/library/papers/4127547 | PubMed |
| 4 | 4138300 | Letter: Epsilon-aminocaproic acid and subarachnoid haemorrhage.?211. | Lancet | 1974 | https://conductscience.org/library/papers/4138300 | PubMed |
| 5 | 4830928 | Earlier operation and antifibrinolytic therapy in the management of aneurysmal subarachnoid haemorrhage. Review of recent experience in Tasmania. | Med J Aust | 1974 | https://conductscience.org/library/papers/4830928 | PubMed |
| 6 | 5026538 | Preoperative management of patients with ruptured intracranial aneurysms. | J Neurosurg | 1972 | https://conductscience.org/library/papers/5026538 | PubMed |
| 7 | 5570768 | Results of a controlled trial of late surgical versus conservative treatment of intracranial arterial aneurysms. | J Neurosurg | 1971 | https://conductscience.org/library/papers/5570768 | PubMed |
| 8 | 5790480 | The use of antifibrinolytic substances in ruptured intracranial aneurysms. | Neurochirurgia (Stuttg) | 1969 | https://conductscience.org/library/papers/5790480 | PubMed |
| 9 | 4268202 | Monitoring antifibrinolytic therapy in subarachnoid hemorrhage. | J Neurosurg | 1973 | https://conductscience.org/library/papers/4268202 | PubMed |
| 10 | 5639737 | Antifibrinolytic therapy for intracranial aneurysms. | J Neurosurg | 1968 | https://conductscience.org/library/papers/5639737 | PubMed |
| 11 | 5921326 | Natural history of subarachnoid hemorrhage, intracranial aneurysms and arteriovenous malformations. | J Neurosurg | 1966 | https://conductscience.org/library/papers/5921326 | PubMed |
| 12 | 1255236 | Use of epsilon aminocaproic acid (EACA) in the preoperative management of ruptured intracranial aneurysms. | J Neurosurg | 1976 | https://conductscience.org/library/papers/1255236 | PubMed |
| 13 | 1185218 | Proceedings: Anterior communicating artery aneurysms. | J Neurol Neurosurg Psychiatry | 1975 | https://conductscience.org/library/papers/1185218 | PubMed |
| 14 | 1185216 | Results of surgical treatment of pericallosal aneurysms. | J Neurol Neurosurg Psychiatry | 1975 | https://conductscience.org/library/papers/1185216 | PubMed |
| 15 | 1198627 | Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage. | Stroke | 1975 | https://conductscience.org/library/papers/1198627 | PubMed |
| 16 | 4231539 | Comparative studies of fibrinolytic inhibitors in vitro. | Thromb Diath Haemorrh | 1966 | https://conductscience.org/library/papers/4231539 | PubMed |
| 17 | 936974 | Echo-encephalographic study of ventricular dilatation after subarachnoid hemorrhage, with special reference to the effect of antifibrinolytic treatment. | Acta Neurol Scand | 1976 | https://conductscience.org/library/papers/936974 | PubMed |
| 18 | 5547318 | The effect of epsilon aminocaproic acid and tranexamic acid on thrombus size and strength in a simulated arterial aneurysm. | J Neurosurg | 1971 | https://conductscience.org/library/papers/5547318 | PubMed |
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 82 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42095754 | European Stroke Organisation (ESO), European Association of Neurosurgical Societies (EANS) and European Society for Minimally Invasive Neurological Therapy (ESMINT) guideline on aneurysmal subarachnoid haemorrhage. | Eur Stroke J | 2026 | https://conductscience.org/library/papers/42095754 | PubMed |
| 40599738 | Efficacy and safety of tranexamic acid administration for subarachnoid hemorrhage: a systematic review and meta-analysis. | Front Neurol | 2025 | https://conductscience.org/library/papers/40599738 | PubMed |
| 40316838 | Relationship between Tranexamic Acid Use and Safety in Patients with Acute Brain Injury: A Systematic Review and Meta-analysis of Mortality and Thromboembolic Events. | CNS Drugs | 2025 | https://conductscience.org/library/papers/40316838 | PubMed |
| 37228855 | The efficacy of antifibrinolytic therapy in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. | Future Sci OA | 2023 | https://conductscience.org/library/papers/37228855 | PubMed |
| 37000863 | Efficacy and safety of tranexamic acid in intracranial haemorrhage: A meta-analysis. | PLoS One | 2023 | https://conductscience.org/library/papers/37000863 | PubMed |
| 36350005 | Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. | Cochrane Database Syst Rev | 2022 | https://conductscience.org/library/papers/36350005 | PubMed |
| 35140671 | Safety and Efficacy of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis of Randomized Controlled Trials. | Front Neurol | 2021 | https://conductscience.org/library/papers/35140671 | PubMed |
| 35083272 | Efficacy and Safety of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | Front Surg | 2021 | https://conductscience.org/library/papers/35083272 | PubMed |
| 34677620 | Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine. | Intensive Care Med | 2021 | https://conductscience.org/library/papers/34677620 | PubMed |
| 34315966 | Tranexamic acid in non-traumatic intracranial bleeding: a systematic review and meta-analysis. | Sci Rep | 2021 | https://conductscience.org/library/papers/34315966 | PubMed |
| 33851983 | Association of Intravenous Tranexamic Acid With Thromboembolic Events and Mortality: A Systematic Review, Meta-analysis, and Meta-regression. | JAMA Surg | 2021 | https://conductscience.org/library/papers/33851983 | PubMed |
| 31360727 | Evaluation of Vascular Endothelial Growth Factor A and Selected Parameters of Coagulation and Fibrinolysis in a Group of Patients with Subarachnoid Haemorrhage. | Biomed Res Int | 2019 | https://conductscience.org/library/papers/31360727 | PubMed |
| 30741383 | Tranexamic Acid in Cerebral Hemorrhage: A Meta-Analysis and Systematic Review. | CNS Drugs | 2019 | https://conductscience.org/library/papers/30741383 | PubMed |
| 23990381 | Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. | Cochrane Database Syst Rev | 2013 | https://conductscience.org/library/papers/23990381 | PubMed |
| 21761274 | Rebleeding after aneurysmal subarachnoid hemorrhage. | Neurocrit Care | 2011 | https://conductscience.org/library/papers/21761274 | PubMed |
| 18386187 | Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage. | Neurocrit Care | 2008 | https://conductscience.org/library/papers/18386187 | PubMed |
| 10400410 | Tranexamic acid: a review of its use in surgery and other indications. | Drugs | 1999 | https://conductscience.org/library/papers/10400410 | PubMed |
| 9854979 | Systematic review of antifibrinolytic treatment in aneurysmal subarachnoid haemorrhage. | J Neurol Neurosurg Psychiatry | 1998 | https://conductscience.org/library/papers/9854979 | PubMed |
| 7435290 | Letter to the editors of acta neurochirurgica. Management of patients with subarachnoid haemorrhage with tranexamic acid. | Acta Neurochir (Wien) | 1980 | https://conductscience.org/library/papers/7435290 | PubMed |
| 7359154 | Monitoring fibrinolytic activity in the cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: a guide to the risk of rebleeding? | J Neurol Neurosurg Psychiatry | 1980 | https://conductscience.org/library/papers/7359154 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/346153
GET https://conductscience.org/api/papers/v1/346153/cited_by?page=2